James L Tyree
CIK 1324991 · Executive Vice President · last filed 2025-08-29
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$6.23M
Companies
7
Total Filings
67
Lifetime Open-Market Net
-$19.50M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| GNLX | Director | 68,074 | $2.96 | $201.5K | -$132.0K | 10 | 2025-08-29 |
| ASRT | Director | 188,251 | $23.48 | $4.42M | -$375.4K | 8 | 2024-03-15 |
| CCXI | Director | 0 | $10.22 | $0 | -$3.17M | 18 | 2022-10-24 |
| Assertio Therapeutics, Inc (DEPO) Delisted | Director | — | — | — | $0 | 3 | 2018-05-10 |
| INVA | Director | 70,554 | $22.74 | $1.60M | -$8.5K | 3 | 2017-04-24 |
| Innoviva, Inc. (THRX) Delisted | Director | 33,182 | $4.06 | $134.7K | -$41.1K | 3 | 2015-06-04 |
| ABBOTT LABORATORIES (ABTw) Delisted | Executive Vice President | 134,575 | — | — | -$15.77M | 22 | 2009-03-03 |
Recent Filings · Page 5 of 7
67 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2015-04-27 | Innoviva, Inc. (THRX) Delisted | Grant (A) | +13,950 | $0 | EDGAR |
| 2014-12-23 | Innoviva, Inc. (THRX) Delisted | Grant (A) | +6,500 | $0 | EDGAR |
| 2013-05-28 | CCXI | Grant (A) | — | $0 | EDGAR |
| 2012-06-26 | CCXI | Grant (A) | — | $0 | EDGAR |
| 2012-06-07 | CCXI | Grant (A) | — | $0 | EDGAR |
| 2009-03-03 | ABBOTT LABORATORIES (ABTw) Delisted | Mixed | −17,267 | -$843.1K | EDGAR |
| 2009-02-24 | ABBOTT LABORATORIES (ABTw) Delisted | Grant (A) | +45,800 | $0 | EDGAR |
| 2009-02-19 | ABBOTT LABORATORIES (ABTw) Delisted | Mixed | −8,833 | -$480.6K | EDGAR |
| 2009-02-18 | ABBOTT LABORATORIES (ABTw) Delisted | Mixed | +65,189 | $2.69M | EDGAR |
| 2009-02-04 | ABBOTT LABORATORIES (ABTw) Delisted | Sell (S) | −74,089 | -$4.06M | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.